Literature DB >> 16139477

A role for cyclic-GMP dependent protein kinase in anoikis.

Yali Hou1, Elsie Wong, Jessica Martin, Patricia V Schoenlein, Wolfgang R Dostmann, Darren D Browning.   

Abstract

Anoikis is an essential process in which a loss of adhesion to the substratum alters intracellular signaling pathways that lead to apoptosis. Using phosphorylation of vasodilator stimulated phosphoprotein (VASP) as an indicator of cGMP-dependent protein kinase (PKG) activity in vivo, it was found that suspension of the colon epithelial cell line (CCD841) leads to rapid and transient activation of PKG that lasted several hours. The colon carcinoma lines SW480 and SW620 do not express endogenous PKG, but exogenously expressed PKG was similarly activated upon cell suspension. To determine whether PKG has a role in apoptosis following cell suspension, poly-ADP ribose polymerase (PARP) cleavage and propidium iodide staining were measured. After 24 h in suspension it was found that approximately 50% of CCD841 cells exhibited apoptosis, whereas apoptosis was not detected in either of the colon carcinoma cell lines. Inhibition of type 1 PKG by expression of a dominant negative PKG construct (G1alphaR-GFP), or by incubation with the PKG inhibitor peptide DT-2, blocked apoptosis in suspended CCD841 cells by approximately 50%. Furthermore, expression of exogenous PKG in SW620 and SW480 cells conferred partial sensitivity anoikis. Taken together these findings indicate that PKG has an important role in the induction of apoptosis following suspension of normal colon epithelial cells, and loss of PKG expression in colon tumor cells may contribute to resistance to anoikis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16139477     DOI: 10.1016/j.cellsig.2005.07.015

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  9 in total

1.  PKG inhibits TCF signaling in colon cancer cells by blocking beta-catenin expression and activating FOXO4.

Authors:  I-K Kwon; R Wang; M Thangaraju; H Shuang; K Liu; R Dashwood; N Dulin; V Ganapathy; D D Browning
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

2.  Type-2 cGMP-dependent protein kinase suppresses proliferation and carcinogenesis in the colon epithelium.

Authors:  Bianca N Islam; Sarah K Sharman; Yali Hou; Rui Wang; Justin Ashby; Honglin Li; Kebin Liu; Kenneth J Vega; Darren D Browning
Journal:  Carcinogenesis       Date:  2022-06-27       Impact factor: 4.741

3.  BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation.

Authors:  Benjamin D Hedley; Kedar S Vaidya; Pushar Phadke; Lisa MacKenzie; David W Dales; Carl O Postenka; Ian C MacDonald; Ann F Chambers
Journal:  Clin Exp Metastasis       Date:  2008-06-10       Impact factor: 5.150

4.  Mode of action of cGMP-dependent protein kinase-specific inhibitors probed by photoaffinity cross-linking mass spectrometry.

Authors:  Martijn W H Pinkse; Dirk T S Rijkers; Wolfgang R Dostmann; Albert J R Heck
Journal:  J Biol Chem       Date:  2009-04-15       Impact factor: 5.157

5.  Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis.

Authors:  Manuel A Pallero; Carrie A Elzie; Jiping Chen; Deane F Mosher; Joanne E Murphy-Ullrich
Journal:  FASEB J       Date:  2008-07-24       Impact factor: 5.191

6.  Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration.

Authors:  Eleonora Vighi; Dragana Trifunović; Patricia Veiga-Crespo; Andreas Rentsch; Dorit Hoffmann; Ayse Sahaboglu; Torsten Strasser; Manoj Kulkarni; Evelina Bertolotti; Angelique van den Heuvel; Tobias Peters; Arie Reijerkerk; Thomas Euler; Marius Ueffing; Frank Schwede; Hans-Gottfried Genieser; Pieter Gaillard; Valeria Marigo; Per Ekström; François Paquet-Durand
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-12       Impact factor: 11.205

Review 7.  Hydrogen peroxide - production, fate and role in redox signaling of tumor cells.

Authors:  Claudia Lennicke; Jette Rahn; Rudolf Lichtenfels; Ludger A Wessjohann; Barbara Seliger
Journal:  Cell Commun Signal       Date:  2015-09-14       Impact factor: 5.712

8.  The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatment.

Authors:  Alexandra M Fajardo; Gary A Piazza; Heather N Tinsley
Journal:  Cancers (Basel)       Date:  2014-02-26       Impact factor: 6.639

9.  cGMP-Dependent Protein Kinase Inhibitors in Health and Disease.

Authors:  Stefanie Wolfertstetter; Johannes P Huettner; Jens Schlossmann
Journal:  Pharmaceuticals (Basel)       Date:  2013-02-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.